Nan Fung Group Holdings LTD Vincerx Pharma, Inc. Transaction History

Nan Fung Group Holdings LTD

  • $101 Million
  • Q4 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.0 - $0.0 $0 - $0
-11,050 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.0 - $0.0 $0 - $0
11,050 New
11,050 $113,000

Others Institutions Holding VINC

# of Institutions
19
Shares Held
3.09M
Call Options Held
0
Put Options Held
0
View Full List

About Vincerx Pharma, Inc.

VINC Quotes by TradingView
  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $1.06M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email